Science and Development Network
News, views and information about science, technology and the developing world
Tuberculosis kills over one and a half million people each year, while governments struggle with inadequate infrastructure and the increasing threat of drug-resistant strains and co-infection with HIV/AIDS.
(Photo credit: Gary Hampton/The Global Fund)
A Peruvian clinic's treatment of extensively drug-resistant tuberculosis is an example to the developing world, says Mario C. Raviglione.
11 August 2008
|
EN
|
ES
Source: New England Journal of Medicine
Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.
11 February 2008
|
EN
Source: British Medical Journal
An assessment of national tuberculosis policies in select countries emphasises the need for more public engagement.
27 June 2007
|
EN
Source: Open Society Institute
The challenge of setting policy priorities for infectious diseases in Myanmar's current political climate.
27 June 2007
|
EN
Source: PLoS Medicine
Scientists have recommended the antiretroviral drug efavirenz for patients suffering from both HIV and tuberculosis.
About 60 per cent of the patients with extensively drug-resistant tuberculosis can be cured by combining five different drugs, says a study.
11 August 2008
|
ES
2 July 2008
|
EN
Beijing's air pollution monitoring will be watched during the Olympics and beyond
An epidemic of kidney disease among farming communities is puzzling Sri Lankan researchers